The makers of Ozempic and Zepbound are fighting to stop compounded copies of their drugs. But it’s unclear whether they can ...
which treat diabetes and obesity, respectively. While these two medicines are grabbing most of the attention, it's worth ...
The United States Federal Trade Commission (FTC) filed an administrative complaint against the nation’s three largest ...
Attorneys for the school district say that the legal action is in part due to self-funded insurance plans that has possibly ...
Novo Nordisk and Eli Lilly are facing scores of personal injury claims for allegedly failing to warn patients about side ...
Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out ...
The Hawkins County Board of Education will consider entering a national lawsuit regarding alleged insulin price fixing that drove up the cost of healthcare nationwide, including health insurance costs ...
The South African Health Products Regulatory Authority (Sahpra ... Since Novo Nordisk and Eli Lilly’s medications have been ...
The continued use of a new obesity treatment can lead to weight loss of up to 23 per cent and a 94 per cent reduction in ...
Pfizer and Lilly’s telehealth prescribing platforms draw Senate scrutiny for ‘potential fraud’
Eli Lilly launched LillyDirect to help patients with obesity, diabetes and migraine navigate a complex healthcare system, a ...
Weekly tirzepatide (Zepbound® and Mounjaro®) injections (pooled 5 mg, 10 mg, 15 mg doses) significantly reduced the risk of progression to type 2 diabetes ... Eli Lilly and Company (NYSE: LLY) ...
In the United Kingdom, the government is hoping weight loss drugs might improve public finances, eyeing their use to help ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback